Vemlidy

DRUG2 trials

Sponsors

National Taiwan University Hospital, Yonsei University

Conditions

Chronic Hepatitis bHepatitis B ReactivationPatients With Malignant Blood Disease Requiring Hepatitis B Antiviral Medication

Phase 4

Chronic Hepatitis b Patients Switch to tAf After Discontinuation of Nucleoside Analogue

Active, not recruitingNCT04496882

National Taiwan University HospitalChronic Hepatitis b, Hepatitis B Reactivation

Start: 2020-09-09End: 2026-12-31Target: 260Updated: 2026-02-24

Clinical Trial for Non-inferiority and Safety of Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in Patients With Hematologic Malignancies Who Require Prophylactic Hepatitis B Antiviral Treatment

Not yet recruitingNCT06221657

Yonsei UniversityPatients With Malignant Blood Disease Requiring Hepatitis B Antiviral Medication

Start: 2024-02-01End: 2026-12-31Target: 100Updated: 2024-01-24